Skip to main content
Clinical Trials/NCT05912010
NCT05912010
Completed
N/A

A Study on Pathogenic Surveillance and Nasopharyngeal Carriage of Children and Adolescents Based on Hospitals and Communities in Hainan Province

Huashan Hospital5 sites in 1 country3,746 target enrollmentApril 24, 2023
ConditionsPneumonia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pneumonia
Sponsor
Huashan Hospital
Enrollment
3746
Locations
5
Primary Endpoint
Correaltion index of disease status of infection with different pathogens
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

This study intends to screen children under the age of 10 for respiratory pathogens, Streptococcus pneumoniae, and serotyping in three representative cities in Hainan province: Haikou, Wanning, and Baisha, in order to provide a foundation for the subsequent promotion of Streptococcus pneumoniae vaccines.

Detailed Description

The purpose of this multi-center epidemiological study was to determine the carrier status of clinically diagnosed pneumonia, pathogen spectrum of clinically diagnosed pneumonia, serotype distribution, and drug resistance profile of Streptococcus pneumoniae in sick children from hospitals and healthy children from the community.

Registry
clinicaltrials.gov
Start Date
April 24, 2023
End Date
December 31, 2024
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Wen-hong Zhang

Director of Division of Infectious Diseases Affiliation: Huashan Hospital

Huashan Hospital

Eligibility Criteria

Inclusion Criteria

  • Case group: patients from fever clinics and pediatric wards
  • Patients with at least one of the following will be clinically diagnosed with pneumonia and recommended for NP/OP, blood cultures, or induced sputum as clinically indicated (TB only or if performed routinely by the clinician), bronchoalveolar lavage fluid (BALF , according to clinical requirements), pleural effusion (according to clinical requirements), and chest X-ray examination:
  • Shortness of breath ( children \<2 months, respiratory rate ≥60 breaths/min; children ≥2 months to \<12 months, respiratory rate ≥50 breaths/min; children ≥12 months to \< 60 months, respiratory rate ≥40 breaths/min; Children ≥ 60 months to \< 120 months, respiratory rate \> 24 breaths/minute )
  • Rales on lung auscultation
  • Respiratory symptoms and fever ( axillary temperature ≥ 37.5 ℃ or rectal temperature ≥ 38 ℃ )
  • Control group The control group will be randomly selected from the community and frequency-matched 1:1 with the case group according to age group, sex and city.

Exclusion Criteria

  • Hospitalized within the first 14 days, or discharged as a case group within the first 30 days, and lived outside the research center area ;
  • People who affect the research results: patients cannot keep samples or the amount of samples is not enough for testing;
  • Can't cooperate well;
  • The researcher judges that it is not suitable to be included in this study .

Outcomes

Primary Outcomes

Correaltion index of disease status of infection with different pathogens

Time Frame: 1 day

Estimate the association with disease status of infection with pathogens of interest (or combination of pathogens) among children aged\<10 years old hospitalized with clinical diagnosed pneumonia compared to healthy children in the community in Hainan. The study is designed to be the case-control study

Prevalence of pneumococcus

Time Frame: 1 day

Estimate the prevalence of pneumococcus among children aged\<10 years old hospitalized with clinical diagnosed pneumonia, in children seen at outpatient clinics, and among healthy children in the community in Hainan

Correaltion index of high load (>6.9 log10 copies/ml) pneumococcus

Time Frame: 1 day

Estimate the association with disease (i.e., case-control status) of high load (\>6.9 log10 copies/ml) pneumococcus among outpatient or hospitalized patients with clinical diagnosed pneumonia in children aged\<10 years old and among healthy children in the community in Hainan

Secondary Outcomes

  • Estimate the proportions of srotypes in patients and healthy children(1 day)
  • Describe the resistance proportion of antibiotics in different region in Hainan(1 day)

Study Sites (5)

Loading locations...

Similar Trials